ASX Share rice
Sat 15 Aug 2020 - 02:37:am (Sydney)

BGT Share Price

BIO-GENE TECHNOLOGY LTDBGTMaterials

BGT Company Information

Name:

Bio-Gene Technology Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Chemicals

GIC Sub Industry:

Fertilizers & Agricultural Chemicals

Address:

456 Lonsdale Street Melbourne Australia 3000

Phone:

61 3 9628 4178

MD, CEO & Director:

Mr. Richard Jagger BSC (HONS), M.INTL.BUS, GAICD

CFO & Company Sec.:

Mr. Roger McPherson B.Bus, CPA, GAICD

Exec. Director of R&D and Exec. Director:

Mr. Peter Donald May MBA, AFA1M, GAICD

Company Overview:

Bio-Gene Technology Limited, a biotechnology company, engages in developing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. It is involved in developing Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from the leaves of a rare eucalyptus trees. The company has research collaborations with contract research organizations, including cesar Pty Ltd, Eurofins Agroscience Services, Purdue University, and University of Technology to assess insecticidal activity of molecules against a range of insect species; and a research collaboration agreement with James Cook University for the development of a tissue culture system in order to support scale up of future Qcide oil production. It also has collaborations with Pacific Discovery Services for studying Flavocide's mode of action; and Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.

BGT Share Price Information

Shares Issued:

151.12M

Market Capitalisation:

$20.40M

Revenue (TTM):

$1.07M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.018

Profit Margin:

-1.7277

Operating Margin (TTM):

$-1.73

Return On Assets (TTM):

$-0.21

Return On Equity (TTM):

$-0.38

Quarterly Revenue Growth (YOY):

5.452

Gross Profit(TTM):

$583.52K

Diluted Earnings Per Share (TTM):

$-0.016

BGT CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-6,882

Change To Liabilities:

$-218,722

Total Cashflow From Investing Activities:

$-6,882

Net Income:

$-2,055,570

Total Cash From Operating Activities:

$-2,201,479

Depreciation:

$45.56K

Other Cashflow From Investing Activities:

$-4,200

Change To Account Receivables:

$-104,408

Capital Expenditures:

$2.68K

BGT Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-2,055,570

Net Income:

$-2,055,570

Gross Profit:

$505.86K

Operating Income:

$-2,194,316

Other Operating Expenses:

$240.90K

Total Revenue:

$505.86K

Total Operating Expenses:

$2.70M

Cost Of Revenue:

$61.09K

BGT Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$387.90K

Total Liabilities:

$613.61K

Total Stockholder Equity:

$4.95M

Other Current Liabilities:

$199.25K

Total Assets:

$5.56M

Common Stock:

$11.80M

Other Current Assets:

$74.20K

Retained Earnings:

$-7,550,587

Other Liabilities:

$150K

Cash:

$4.50M

Total Current Liabilities:

$463.61K

Property - Plant & Equipment:

$32.71K

Net Tangible Assets:

$4.56M

Total Current Assets:

$5.14M

Net Receivables:

$472.77K

Short-Term Investments:

$420.61K

Accounts Payable:

$123.24K

Non Currrent Assets (Other):

$420.61K

Short-Term Investments:

$420.61

Non Current Liabilities (Other):

$150K

Non Current Liabilities Total:

$150K

BGT Share Price History

BGT News

10 May, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
10 Feb, 2020
Bio-Gene Technology Limited (ASX:BGT) shareholders have seen the share price descend 13% over the month. But that...
12 Nov, 2019
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
14 Sep, 2019
Every investor in Bio-Gene Technology Limited (ASX:BGT) should be aware of the most powerful shareholder groups...